<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>VentureBeat - Latest Comments in Public biotech firms Cadence, Affymax draw $128M from bargain-hunting VCs</title><link>http://venturebeat.disqus.com/</link><description>News about Tech, Business and Innovation</description><atom:link href="https://venturebeat.disqus.com/public_biotech_firms_cadence_affymax_draw_128m_from_bargain_hunting_vcs/latest.rss" rel="self"></atom:link><language>en</language><lastBuildDate>Thu, 26 Feb 2009 23:14:08 -0000</lastBuildDate><item><title>Re: Public biotech firms Cadence, Affymax draw $128M from bargain-hunting VCs</title><link>http://venturebeat.com/2009/02/18/public-biotech-firms-cadence-affymax-draw-128m-from-bargain-hunting-vcs/#comment-6678484</link><description>&lt;p&gt;Heya jennifer, thanks for the link.&lt;/p&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Trini Sario</dc:creator><pubDate>Thu, 26 Feb 2009 23:14:08 -0000</pubDate></item><item><title>Re: Public biotech firms Cadence, Affymax draw $128M from bargain-hunting VCs</title><link>http://venturebeat.com/2009/02/18/public-biotech-firms-cadence-affymax-draw-128m-from-bargain-hunting-vcs/#comment-6522908</link><description>&lt;p&gt;I just read another great article about the Challenges facing the Pharmaceutical and Biotech Industries which discusses what they will need to do to stay competitive in this type of economy.  Here is the link &lt;a href="http://tinyurl.com/attfyo" rel="nofollow noopener" target="_blank" title="http://tinyurl.com/attfyo"&gt;http://tinyurl.com/attfyo&lt;/a&gt; &lt;/p&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">jenniferwilson09</dc:creator><pubDate>Mon, 23 Feb 2009 16:50:45 -0000</pubDate></item></channel></rss>